Michael A. Smith

Michael A. Smith

Auto-generated profile, based on publicly available information

Michael A. Smith

Creighton University School of Medicine, Phoenix Health Sciences Campus, Phoenix, AZ, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2017 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
DNDeepak K. Nayak
Deepak K. Nayak
FZFangyu Zhou
Fangyu Zhou
MXMin Xu
Min Xu
JHJing Huang
Jing Huang
Moriya TsujiMoriya Tsuji
Moriya Tsuji
TMThalachallour Mohanakumar
Thalachallour Mohanakumar
Zbtb7a in alveolar macrophages influences early inflammation and autoimmunity in antibody-mediated rejection of transplanted lungs.

22 September 2022 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Open access
DRDeepika Razia
Deepika Razia
MOMichael T. Olson
Michael T. Olson
KGKatherine Grief
Katherine Grief
RWRajat Walia
Rajat Walia
RBRoss M. Bremner
Ross M. Bremner
STSofya Tokman
Sofya Tokman
Hospitalized lung transplant (LT) recipients (LTRs) have higher post-LT morbidity and mortality than those who are well enough to wait for transplant at home. Outcomes after LT for COVID-19-associated acute respiratory distress syndrome (CARDS) may be even worse; thus, we compared post-LT outcomes between hospitalized LTRs transplanted for CARDS and those transplanted for restrictive lung disease (RLD). Between 2014 and 2021, hospitalized LTRs ≥18 years old with CARDS or RLD were included. Primary and secondary outcomes were 1-year post-LT survival and postoperative morbidity. For each patient in the CARDS group, an analysis of 1-to-1 matched patients from the RLD group was performed using logistic regression modeling. Of 764 LTRs, 163 (21.3%) were hospitalized at the time of LT; 132 met the inclusion criteria: 11 (8.3%) were transplanted for CARDS and 121 (91.7%) for RLD. LTRs with CARDS were younger with longer pre-LT hospitalization stays and higher rates of pretransplant mechanical ventilation, dialysis, and ECMO as a bridge to transplant. A propensity-matched analysis demonstrated comparable rates of intrathoracic adhesions, posttransplant duration of mechanical ventilation, PGD3 at 72 hours, and delayed chest closure. Compared to LTRs with RLD, those with CARDS had significantly longer posttransplant hospital stays and a higher prevalence of ACR ≥A2 and DSA >2000 MFI, but comparable 1-year survival rates. Even with careful selection, LT for patients with CARDS was associated with significant morbidity; however, 1-year survival of recipients with CARDS was comparable to that of matched hospitalized recipients with RLD.

11 February 2022 in Transplantation Direct
Verified
Journal Article
Open access
DRDeepika Razia
Deepika Razia
SMSumeet K. Mittal
Sumeet K. Mittal
SBSandhya Bansal
Sandhya Bansal
RRRanjithkumar Ravichandran
Ranjithkumar Ravichandran
MSMichael A. Smith
Michael A. Smith
STSofya Tokman
Sofya Tokman
Background. Pre–lung transplant (LTx) gastroesophageal reflux (GER) and circulating antibodies against the lung self-antigens (SAbs) collagen V and K-alpha-1 tubulin may predispose recipients to chronic lung allograft dysfunction (CLAD). We aimed to study the association of pre-LTx GER or pre-LTx SAbs with CLAD. Methods. In this retrospective analysis of patients who underwent LTx between 2015 and 2019, pre-LTx GER and SAbs were dichotomously defined as present or absent. The study group comprised recipients with either GER‚ SAbs, or both, and the control group comprised recipients without GER or SAbs. Endpoints included CLAD and survival. Results. Ninety-five LTx recipients were divided into a study group (n = 71; 75%) and a control group (n = 24; 25%). Pretransplant GER was associated with pre-LTx SAbs (odds ratio [95% confidence intervals], 5.022 [1.419-17.770]; P = 0.012). In addition, the study group (either GER‚ SAbs, or both) had a higher risk of CLAD (hazard ratio [95% confidence intervals], 8.787 [1.694-45.567]; P = 0.010) and lower CLAD-free survival after LTx than the control group (P = 0.007); however, overall survival was similar between the 2 groups (P = 0.618). Conclusions. GER was associated with elevated SAbs in LTx candidates, and either GER, SAbs, or both were associated with CLAD in LTx recipients. This association suggests that GER may cause an immune response to normally sequestered lung-associated self-antigens that drives ongoing lung injury.

10 May 2026 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
MOMichael T. Olson
Michael T. Olson
AAAshwini Arjuna
Ashwini Arjuna
MSMark Shacker
Mark Shacker
RWRajat Walia
Rajat Walia
LSLara Schaheen
Lara Schaheen
SRSreeja Biswas Roy
Sreeja Biswas Roy


26 October 2026 in Annals of Thoracic Surgery Short Reports
Verified
Journal Article
Open access
LCLucia Chang
Lucia Chang
MSMark Shacker
Mark Shacker
LWLucas Wang
Lucas Wang
HFHailey Fike
Hailey Fike
AKAndrew Keogan
Andrew Keogan
MSMichael A. Smith
Michael A. Smith